GR

Gade Rambabu

Active Director Director DIN 09030971
DIN 09030971 First appointment Jan 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2021
Shareholding value •••• Premium profile

About Gade Rambabu

Data last updated:

Gade Rambabu is a Director at Erevna Pharma Private Limited (since 2021). The company operates in Pharma. Erevna Pharma Private Limited reported revenue of ₹40 Lakh (FY 2025).

DIN 09030971
Primary Designation Director
Industry Pharma
First Appointment 15 Jan 2021
Oldest Company Age 5 yrs
Largest company Erevna Pharma Private Limited · ₹40 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Erevna Pharma Private Limited U24299TG2021PTC147754
Director15 Jan 20212021₹40 Lakh (FY 2025)Active

Board colleagues of Gade Rambabu

NameDINCompanyDesignation
Balakrishna Naresh Palanki09030970Erevna Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Erevna Pharma Private Limited
Premium access

Shareholding and investment profile for Gade Rambabu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gade Rambabu

Gade Rambabu currently holds 1 directorship: Erevna Pharma Private Limited (Director, since 15 Jan 2021, revenue ₹40 Lakh (FY 2025)).

Gade Rambabu was first appointed on 15 Jan 2021 as Director at Erevna Pharma Private Limited.

The current boards of Gade Rambabu's companies include Balakrishna Naresh Palanki (Erevna Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available